Healthcare Chinese Pre-Profit Cancer Drug Developer Tot Biopharm Files For HK IPO May 3, 2019 β 11:00
Healthcare Chinese Bio-pharmaceutical Company TOT Biopharm Raises $102M Series B Round August 10, 2018 β 11:53
